← All stocks

Organon & Co.

OGN No buying or selling

CIK 0001821825 #1600 in the set updated 18 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

13 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Ali Kevin

Chief Executive Officer

—

282,731

$3.84M

+82.0%

WALSH MATTHEW M

Chief Financial Officer

—

212,746

$2.89M

+129.7%

Morrissey Joseph T. Jr.

Interim CEO

—

123,123

$1.67M

+153.3%

Stahler Rachel A

Chief Information Officer

—

116,105

$1.58M

+101.6%

Falcione Aaron

Chief Human Resources Officer

—

101,431

$1.38M

+173.9%

Weaver Kirke

Gen. Counsel & Corp. Secy.

—

92,639

$1.26M

+198.9%

COX CARRIE SMITH

Executive Chair

—

90,338

$1.23M

+624.5%

Nisita Vittorio

Head of Global Business Svcs

—

70,619

$958.30K

+151.1%

Karp Daniel

Executive VP, Corp. Dev.

—

69,548

$943.77K

+245.9%

Holzbaur Lynette

SVP and Corporate Controller

—

52,851

$717.19K

+386.7%

DiMarco Kathryn

Corporate Controller

—

38,740

$525.70K

+66.0%

Arjona Ferreira Juan Camilo

Head of R&D & CMO

—

37,432

$507.96K

—

Drinane Juliana Papa

Head of Mfg & Supply

—

18,475

$250.70K

+50.1%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 4 Jun 2021